Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.55045908 |
2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.22239536 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.22239536 |
4 | negative regulation of cell killing (GO:0031342) | 4.98222604 |
5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.98222604 |
6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.88593418 |
7 | modulation by symbiont of host defense response (GO:0052031) | 4.88593418 |
8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.88593418 |
9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.88593418 |
10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.88593418 |
11 | modulation by symbiont of host immune response (GO:0052553) | 4.88593418 |
12 | regulation of gamma-delta T cell activation (GO:0046643) | 4.73197729 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.57643325 |
14 | response to peptidoglycan (GO:0032494) | 4.37569358 |
15 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.35145524 |
16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.24862781 |
17 | response to muramyl dipeptide (GO:0032495) | 4.13261752 |
18 | positive regulation of humoral immune response (GO:0002922) | 4.01130542 |
19 | leukocyte aggregation (GO:0070486) | 3.99080211 |
20 | negative regulation of interleukin-12 production (GO:0032695) | 3.86052698 |
21 | response to type I interferon (GO:0034340) | 3.84596207 |
22 | neutrophil activation involved in immune response (GO:0002283) | 3.84509577 |
23 | type I interferon signaling pathway (GO:0060337) | 3.81142711 |
24 | cellular response to type I interferon (GO:0071357) | 3.81142711 |
25 | positive regulation of interferon-alpha production (GO:0032727) | 3.77676672 |
26 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.74463314 |
27 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68388871 |
28 | positive regulation of B cell differentiation (GO:0045579) | 3.66146098 |
29 | regulation of interferon-alpha production (GO:0032647) | 3.63381552 |
30 | positive thymic T cell selection (GO:0045059) | 3.61539865 |
31 | T cell migration (GO:0072678) | 3.61439341 |
32 | negative thymic T cell selection (GO:0045060) | 3.53763571 |
33 | positive regulation of antigen processing and presentation (GO:0002579) | 3.48567370 |
34 | macrophage activation involved in immune response (GO:0002281) | 3.48498206 |
35 | cellular extravasation (GO:0045123) | 3.48431535 |
36 | negative T cell selection (GO:0043383) | 3.47934767 |
37 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.42141674 |
38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41303746 |
39 | regulation of T cell tolerance induction (GO:0002664) | 3.40405709 |
40 | B cell receptor signaling pathway (GO:0050853) | 3.38521266 |
41 | respiratory burst (GO:0045730) | 3.29542121 |
42 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.29017324 |
43 | response to host immune response (GO:0052572) | 3.28011614 |
44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.28011614 |
45 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.27263870 |
46 | neutrophil mediated immunity (GO:0002446) | 3.26669928 |
47 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.24223322 |
48 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.23444267 |
49 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.23218890 |
50 | B cell mediated immunity (GO:0019724) | 3.21561302 |
51 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.21460946 |
52 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.16633605 |
53 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.16082010 |
54 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15452749 |
55 | negative regulation of T cell mediated immunity (GO:0002710) | 3.15194239 |
56 | regulation of tolerance induction (GO:0002643) | 3.15070807 |
57 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.12869257 |
58 | germinal center formation (GO:0002467) | 3.11281220 |
59 | natural killer cell mediated immunity (GO:0002228) | 3.10225345 |
60 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.10225345 |
61 | immunoglobulin mediated immune response (GO:0016064) | 3.08744653 |
62 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.07260031 |
63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.06967264 |
64 | detection of external biotic stimulus (GO:0098581) | 3.05272362 |
65 | myeloid dendritic cell activation (GO:0001773) | 3.04706903 |
66 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03787802 |
67 | response to host (GO:0075136) | 3.03715151 |
68 | response to host defenses (GO:0052200) | 3.03715151 |
69 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.03715151 |
70 | modulation by symbiont of host cellular process (GO:0044068) | 3.03308157 |
71 | myeloid cell activation involved in immune response (GO:0002275) | 3.02366667 |
72 | mannose metabolic process (GO:0006013) | 3.01742851 |
73 | * NIK/NF-kappaB signaling (GO:0038061) | 3.01358727 |
74 | positive regulation of interferon-beta production (GO:0032728) | 3.00654353 |
75 | leukocyte cell-cell adhesion (GO:0007159) | 3.00541222 |
76 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.99915036 |
77 | regulation of antigen processing and presentation (GO:0002577) | 2.98213503 |
78 | regulation of B cell differentiation (GO:0045577) | 2.97934848 |
79 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97378965 |
80 | regulation of mast cell degranulation (GO:0043304) | 2.97240255 |
81 | response to interferon-alpha (GO:0035455) | 2.96562805 |
82 | thymic T cell selection (GO:0045061) | 2.95530485 |
83 | neutrophil activation (GO:0042119) | 2.92429589 |
84 | myeloid dendritic cell differentiation (GO:0043011) | 2.91192678 |
85 | granulocyte activation (GO:0036230) | 2.90400032 |
86 | T cell selection (GO:0045058) | 2.89339659 |
87 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.89199649 |
88 | positive regulation of B cell mediated immunity (GO:0002714) | 2.89199649 |
89 | cellular response to virus (GO:0098586) | 2.89113132 |
90 | detection of other organism (GO:0098543) | 2.88866330 |
91 | positive T cell selection (GO:0043368) | 2.88828414 |
92 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.87517807 |
93 | tolerance induction (GO:0002507) | 2.86187844 |
94 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.86178119 |
95 | detection of bacterium (GO:0016045) | 2.84703178 |
96 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.84090296 |
97 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83862710 |
98 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.83573831 |
99 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.83260146 |
100 | regulation of growth of symbiont in host (GO:0044126) | 2.83260146 |
101 | negative regulation of growth of symbiont in host (GO:0044130) | 2.83260146 |
102 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.83260146 |
103 | defense response to protozoan (GO:0042832) | 2.82411789 |
104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.82007167 |
105 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81937387 |
106 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81937387 |
107 | detection of molecule of bacterial origin (GO:0032490) | 2.81904673 |
108 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.81769573 |
109 | positive regulation of tolerance induction (GO:0002645) | 2.80646802 |
110 | negative regulation of innate immune response (GO:0045824) | 2.80187082 |
111 | microglial cell activation (GO:0001774) | 2.79625137 |
112 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.79404575 |
113 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.78969580 |
114 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.75549888 |
115 | macrophage activation (GO:0042116) | 2.75247335 |
116 | response to interleukin-15 (GO:0070672) | 2.75232574 |
117 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.74815226 |
118 | detection of biotic stimulus (GO:0009595) | 2.74649436 |
119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.74622840 |
120 | response to protozoan (GO:0001562) | 2.74134289 |
121 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.73557587 |
122 | regulation of lymphocyte migration (GO:2000401) | 2.73528149 |
123 | mature B cell differentiation (GO:0002335) | 2.72875878 |
124 | regulation of leukocyte degranulation (GO:0043300) | 2.70581972 |
125 | cytokine secretion (GO:0050663) | 2.70087426 |
126 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.68954082 |
127 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.68496932 |
128 | leukocyte mediated cytotoxicity (GO:0001909) | 2.68077365 |
129 | negative regulation of phagocytosis (GO:0050765) | 2.67771643 |
130 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.67190663 |
131 | regulation of interleukin-12 production (GO:0032655) | 2.67181484 |
132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65521533 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.93085233 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.92642367 |
3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.36268626 |
4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.30741449 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.03424709 |
6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.00062485 |
7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.56396558 |
8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.41635963 |
9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.41097102 |
10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.40867911 |
11 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.17663601 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.95494091 |
13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.93573038 |
14 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.64021869 |
15 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.61153910 |
16 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.59621213 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.57490726 |
18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.50329537 |
19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.47107342 |
20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.38418230 |
21 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.33386223 |
22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.33095611 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21863981 |
24 | MYB_26560356_Chip-Seq_TH2_Human | 2.18711020 |
25 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.13631924 |
26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.12153185 |
27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.03896594 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02053015 |
29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00418460 |
30 | * MYB_26560356_Chip-Seq_TH1_Human | 1.99565624 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97424822 |
32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.95646272 |
33 | MYC_22102868_ChIP-Seq_BL_Human | 1.87482671 |
34 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.85883698 |
35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.85057263 |
36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.76438183 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.75547926 |
38 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.71132104 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.69174496 |
40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.68083184 |
41 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.65865897 |
42 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.64501984 |
43 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.64492835 |
44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.62567833 |
45 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.61782843 |
46 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59580485 |
47 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.59274582 |
48 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58262631 |
49 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52354714 |
50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51476658 |
51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50118474 |
52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48261377 |
53 | GATA1_22025678_ChIP-Seq_K562_Human | 1.47566712 |
54 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.44734616 |
55 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44708083 |
56 | MAF_26560356_Chip-Seq_TH2_Human | 1.42130060 |
57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41740215 |
58 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41602863 |
59 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.41047299 |
60 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40679387 |
61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.36169923 |
62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34983478 |
63 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32166722 |
64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.31085077 |
65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.26979717 |
66 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.26884713 |
67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.25770748 |
68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23305041 |
69 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22661875 |
70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.21547230 |
71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21453696 |
72 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20718393 |
73 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19984036 |
74 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19097042 |
75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.18452059 |
76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17872788 |
77 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.16336988 |
78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15119249 |
79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14109956 |
80 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13062569 |
81 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12609557 |
82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12063584 |
83 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.11745810 |
84 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08493661 |
85 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07681551 |
86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06915713 |
87 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05793945 |
88 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05163331 |
89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04989034 |
90 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04942250 |
91 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03562440 |
92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99035597 |
93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98688533 |
94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97736539 |
95 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97660460 |
96 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.96986640 |
97 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93277556 |
98 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92350501 |
99 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91436101 |
100 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91412860 |
101 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.90955391 |
102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90338297 |
103 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.86908372 |
104 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.85574148 |
105 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.85482872 |
106 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84478154 |
107 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84379783 |
108 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84315771 |
109 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84171131 |
110 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84101839 |
111 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.83494083 |
112 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.82744915 |
113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81882608 |
114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81225979 |
115 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78804301 |
116 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77570465 |
117 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77471865 |
118 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.75495560 |
119 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.75454143 |
120 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74569102 |
121 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.73003114 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.73295891 |
2 | MP0003436_decreased_susceptibility_to | 3.40183623 |
3 | MP0000685_abnormal_immune_system | 3.32502875 |
4 | MP0009785_altered_susceptibility_to | 3.29476523 |
5 | MP0003303_peritoneal_inflammation | 2.88207448 |
6 | MP0005387_immune_system_phenotype | 2.86405768 |
7 | MP0001790_abnormal_immune_system | 2.86405768 |
8 | MP0002419_abnormal_innate_immunity | 2.76846563 |
9 | * MP0005025_abnormal_response_to | 2.76306286 |
10 | MP0005000_abnormal_immune_tolerance | 2.75224071 |
11 | MP0001800_abnormal_humoral_immune | 2.70108833 |
12 | MP0000569_abnormal_digit_pigmentation | 2.63527602 |
13 | MP0005671_abnormal_response_to | 2.60346019 |
14 | MP0003763_abnormal_thymus_physiology | 2.54429794 |
15 | MP0002723_abnormal_immune_serum | 2.50150787 |
16 | MP0002452_abnormal_antigen_presenting | 2.48566620 |
17 | MP0002148_abnormal_hypersensitivity_rea | 2.45122663 |
18 | MP0005464_abnormal_platelet_physiology | 2.40446421 |
19 | MP0003724_increased_susceptibility_to | 2.37966083 |
20 | MP0004947_skin_inflammation | 2.32027286 |
21 | MP0001819_abnormal_immune_cell | 2.29301038 |
22 | MP0002420_abnormal_adaptive_immunity | 2.28546279 |
23 | MP0006082_CNS_inflammation | 2.19999290 |
24 | MP0005058_abnormal_lysosome_morphology | 2.11755924 |
25 | MP0009278_abnormal_bone_marrow | 2.07178210 |
26 | MP0002166_altered_tumor_susceptibility | 2.05042937 |
27 | MP0010155_abnormal_intestine_physiology | 1.98304285 |
28 | MP0003172_abnormal_lysosome_physiology | 1.97223683 |
29 | MP0004510_myositis | 1.95438947 |
30 | MP0002398_abnormal_bone_marrow | 1.89940557 |
31 | * MP0002405_respiratory_system_inflammati | 1.88990329 |
32 | MP0001845_abnormal_inflammatory_respons | 1.84625761 |
33 | MP0000716_abnormal_immune_system | 1.81917178 |
34 | MP0003300_gastrointestinal_ulcer | 1.79880539 |
35 | MP0002006_tumorigenesis | 1.72528911 |
36 | MP0009840_abnormal_foam_cell | 1.70491439 |
37 | MP0001873_stomach_inflammation | 1.70077630 |
38 | MP0001533_abnormal_skeleton_physiology | 1.67578164 |
39 | MP0009333_abnormal_splenocyte_physiolog | 1.65497005 |
40 | MP0001545_abnormal_hematopoietic_system | 1.64497939 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.64497939 |
42 | MP0000689_abnormal_spleen_morphology | 1.62617458 |
43 | MP0005174_abnormal_tail_pigmentation | 1.62115830 |
44 | MP0008469_abnormal_protein_level | 1.61104463 |
45 | MP0001853_heart_inflammation | 1.60393506 |
46 | MP0003183_abnormal_peptide_metabolism | 1.56959878 |
47 | MP0002722_abnormal_immune_system | 1.53659699 |
48 | MP0002396_abnormal_hematopoietic_system | 1.53277221 |
49 | MP0002429_abnormal_blood_cell | 1.48497640 |
50 | MP0009764_decreased_sensitivity_to | 1.48202326 |
51 | MP0003806_abnormal_nucleotide_metabolis | 1.45867357 |
52 | MP0005360_urolithiasis | 1.33635747 |
53 | MP0003448_altered_tumor_morphology | 1.30088215 |
54 | MP0000858_altered_metastatic_potential | 1.29384554 |
55 | MP0000703_abnormal_thymus_morphology | 1.25304786 |
56 | MP0005083_abnormal_biliary_tract | 1.23880514 |
57 | MP0003191_abnormal_cellular_cholesterol | 1.23600701 |
58 | MP0003866_abnormal_defecation | 1.22554788 |
59 | MP0009763_increased_sensitivity_to | 1.21189696 |
60 | MP0000604_amyloidosis | 1.16488826 |
61 | MP0002254_reproductive_system_inflammat | 1.16293254 |
62 | MP0004381_abnormal_hair_follicle | 1.15013924 |
63 | MP0002998_abnormal_bone_remodeling | 1.14046757 |
64 | MP0004808_abnormal_hematopoietic_stem | 1.14003730 |
65 | MP0002139_abnormal_hepatobiliary_system | 1.10309767 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.08133840 |
67 | MP0002933_joint_inflammation | 1.07192131 |
68 | MP0001851_eye_inflammation | 1.03998582 |
69 | MP0005310_abnormal_salivary_gland | 1.02817097 |
70 | MP0000371_diluted_coat_color | 1.00022457 |
71 | MP0000609_abnormal_liver_physiology | 0.99308767 |
72 | MP0010352_gastrointestinal_tract_polyps | 0.98229067 |
73 | MP0000343_altered_response_to | 0.98092894 |
74 | MP0008004_abnormal_stomach_pH | 0.97991994 |
75 | MP0002132_abnormal_respiratory_system | 0.97430788 |
76 | MP0008260_abnormal_autophagy | 0.96556015 |
77 | MP0003075_altered_response_to | 0.94467456 |
78 | MP0002138_abnormal_hepatobiliary_system | 0.93370609 |
79 | MP0004883_abnormal_blood_vessel | 0.93109098 |
80 | MP0005365_abnormal_bile_salt | 0.92091296 |
81 | MP0005451_abnormal_body_composition | 0.91772070 |
82 | MP0000015_abnormal_ear_pigmentation | 0.89094488 |
83 | MP0003453_abnormal_keratinocyte_physiol | 0.88582856 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.88404535 |
85 | MP0005164_abnormal_response_to | 0.88157395 |
86 | MP0005075_abnormal_melanosome_morpholog | 0.87961457 |
87 | MP0000490_abnormal_crypts_of | 0.87077474 |
88 | MP0005076_abnormal_cell_differentiation | 0.86123522 |
89 | MP0005023_abnormal_wound_healing | 0.85366569 |
90 | MP0010307_abnormal_tumor_latency | 0.82893870 |
91 | MP0003795_abnormal_bone_structure | 0.82672761 |
92 | MP0009765_abnormal_xenobiotic_induced | 0.82034412 |
93 | MP0005166_decreased_susceptibility_to | 0.74332984 |
94 | MP0003566_abnormal_cell_adhesion | 0.73081125 |
95 | MP0003091_abnormal_cell_migration | 0.71517282 |
96 | MP0002877_abnormal_melanocyte_morpholog | 0.71035993 |
97 | MP0005390_skeleton_phenotype | 0.69701856 |
98 | MP0002277_abnormal_respiratory_mucosa | 0.68012896 |
99 | MP0000249_abnormal_blood_vessel | 0.67718857 |
100 | MP0003828_pulmonary_edema | 0.64999267 |
101 | MP0000598_abnormal_liver_morphology | 0.64924757 |
102 | MP0006054_spinal_hemorrhage | 0.64548527 |
103 | MP0003690_abnormal_glial_cell | 0.64264404 |
104 | MP0002136_abnormal_kidney_physiology | 0.63936194 |
105 | MP0005085_abnormal_gallbladder_physiolo | 0.63885997 |
106 | MP0002019_abnormal_tumor_incidence | 0.62120483 |
107 | MP0010329_abnormal_lipoprotein_level | 0.61049301 |
108 | MP0001663_abnormal_digestive_system | 0.61018429 |
109 | MP0003279_aneurysm | 0.60908890 |
110 | MP0001191_abnormal_skin_condition | 0.60751995 |
111 | MP0003329_amyloid_beta_deposits | 0.59177287 |
112 | MP0008874_decreased_physiological_sensi | 0.57247191 |
113 | MP0001542_abnormal_bone_strength | 0.53687716 |
114 | MP0005165_increased_susceptibility_to | 0.52395147 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.57538892 |
2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.55381451 |
3 | Eczematoid dermatitis (HP:0000976) | 5.46126532 |
4 | Recurrent bacterial skin infections (HP:0005406) | 5.20712878 |
5 | Stomatitis (HP:0010280) | 5.09979904 |
6 | Myositis (HP:0100614) | 4.66116335 |
7 | Autoimmune thrombocytopenia (HP:0001973) | 4.63478251 |
8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.59668294 |
9 | Mediastinal lymphadenopathy (HP:0100721) | 4.20523975 |
10 | Recurrent fungal infections (HP:0002841) | 4.11670659 |
11 | Orchitis (HP:0100796) | 4.10938394 |
12 | Pustule (HP:0200039) | 3.99117730 |
13 | Retrobulbar optic neuritis (HP:0100654) | 3.98894095 |
14 | Optic neuritis (HP:0100653) | 3.98894095 |
15 | Abnormality of macrophages (HP:0004311) | 3.96741520 |
16 | Recurrent viral infections (HP:0004429) | 3.91786328 |
17 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.74156031 |
18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.74156031 |
19 | Abnormality of glycolipid metabolism (HP:0010969) | 3.74156031 |
20 | Recurrent skin infections (HP:0001581) | 3.71495164 |
21 | Periodontitis (HP:0000704) | 3.58769561 |
22 | Gingivitis (HP:0000230) | 3.52960405 |
23 | Vasculitis (HP:0002633) | 3.46795655 |
24 | Abnormality of T cell number (HP:0011839) | 3.33883353 |
25 | Chronic otitis media (HP:0000389) | 3.32469506 |
26 | Agammaglobulinemia (HP:0004432) | 3.31950334 |
27 | Gingival bleeding (HP:0000225) | 3.28366071 |
28 | T lymphocytopenia (HP:0005403) | 3.27427449 |
29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.23767155 |
30 | Recurrent cutaneous fungal infections (HP:0011370) | 3.23767155 |
31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22682928 |
32 | Pulmonary infiltrates (HP:0002113) | 3.19283506 |
33 | Leukocytosis (HP:0001974) | 3.08721657 |
34 | Dysostosis multiplex (HP:0000943) | 3.05876289 |
35 | Obstructive lung disease (HP:0006536) | 3.05814884 |
36 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05814884 |
37 | Vacuolated lymphocytes (HP:0001922) | 3.05054786 |
38 | Meningitis (HP:0001287) | 2.92821729 |
39 | Arterial thrombosis (HP:0004420) | 2.89092227 |
40 | Joint hemorrhage (HP:0005261) | 2.82703770 |
41 | Loss of speech (HP:0002371) | 2.80041891 |
42 | Abnormality of T cells (HP:0002843) | 2.79707486 |
43 | Nasal polyposis (HP:0100582) | 2.75542126 |
44 | Gastrointestinal stroma tumor (HP:0100723) | 2.75059676 |
45 | Epistaxis (HP:0000421) | 2.74543270 |
46 | Petechiae (HP:0000967) | 2.73224913 |
47 | Increased IgE level (HP:0003212) | 2.70250987 |
48 | Hemoptysis (HP:0002105) | 2.68721635 |
49 | Amyloidosis (HP:0011034) | 2.68163516 |
50 | Keratoconjunctivitis sicca (HP:0001097) | 2.61658937 |
51 | Joint swelling (HP:0001386) | 2.59857347 |
52 | Eosinophilia (HP:0001880) | 2.59564237 |
53 | Thrombocytosis (HP:0001894) | 2.57506448 |
54 | Urticaria (HP:0001025) | 2.55346344 |
55 | Increased cerebral lipofuscin (HP:0011813) | 2.53404737 |
56 | Gastrointestinal infarctions (HP:0005244) | 2.53141231 |
57 | Recurrent bronchitis (HP:0002837) | 2.52678231 |
58 | Autoimmune hemolytic anemia (HP:0001890) | 2.51353227 |
59 | Keratoconjunctivitis (HP:0001096) | 2.48752339 |
60 | Myocardial infarction (HP:0001658) | 2.47272398 |
61 | Increased IgM level (HP:0003496) | 2.45584390 |
62 | Abnormality of T cell physiology (HP:0011840) | 2.45033219 |
63 | Hypergammaglobulinemia (HP:0010702) | 2.44856222 |
64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.40308434 |
65 | Increased serum ferritin (HP:0003281) | 2.39340528 |
66 | Hepatosplenomegaly (HP:0001433) | 2.39217060 |
67 | Spontaneous hematomas (HP:0007420) | 2.37715185 |
68 | Systemic lupus erythematosus (HP:0002725) | 2.37026982 |
69 | Abnormality of the fingertips (HP:0001211) | 2.36648120 |
70 | Abnormality of the nasal mucosa (HP:0000433) | 2.34656036 |
71 | Abnormality of eosinophils (HP:0001879) | 2.31457718 |
72 | Thick nail (HP:0001805) | 2.31272388 |
73 | Inflammation of the large intestine (HP:0002037) | 2.30987184 |
74 | Cellulitis (HP:0100658) | 2.30930107 |
75 | Prolonged bleeding time (HP:0003010) | 2.30519363 |
76 | Interstitial pulmonary disease (HP:0006530) | 2.29329109 |
77 | Premature loss of primary teeth (HP:0006323) | 2.27597086 |
78 | Prostate neoplasm (HP:0100787) | 2.26551955 |
79 | Purpura (HP:0000979) | 2.25823546 |
80 | Chest pain (HP:0100749) | 2.25419048 |
81 | Granulocytopenia (HP:0001913) | 2.24071205 |
82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.23094045 |
83 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.23094045 |
84 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.23094045 |
85 | Sepsis (HP:0100806) | 2.21221734 |
86 | Osteomyelitis (HP:0002754) | 2.20512534 |
87 | Gastrointestinal inflammation (HP:0004386) | 2.18205373 |
88 | Colitis (HP:0002583) | 2.17584397 |
89 | Abnormality of the prostate (HP:0008775) | 2.16964383 |
90 | Combined immunodeficiency (HP:0005387) | 2.14919251 |
91 | Panhypogammaglobulinemia (HP:0003139) | 2.14676018 |
92 | Encephalitis (HP:0002383) | 2.12653923 |
93 | Verrucae (HP:0200043) | 2.12154416 |
94 | Papilloma (HP:0012740) | 2.12154416 |
95 | Frequent falls (HP:0002359) | 2.10911862 |
96 | Mucopolysacchariduria (HP:0008155) | 2.10398758 |
97 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10398758 |
98 | Menorrhagia (HP:0000132) | 2.10285933 |
99 | Progressive neurologic deterioration (HP:0002344) | 2.09080613 |
100 | Severe combined immunodeficiency (HP:0004430) | 2.06690264 |
101 | Pulmonary embolism (HP:0002204) | 2.06052492 |
102 | IgG deficiency (HP:0004315) | 2.05585452 |
103 | Hematochezia (HP:0002573) | 2.04695224 |
104 | Gangrene (HP:0100758) | 2.04422712 |
105 | Abnormality of iron homeostasis (HP:0011031) | 2.03159580 |
106 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.01825595 |
107 | Tetraparesis (HP:0002273) | 2.01154310 |
108 | IgM deficiency (HP:0002850) | 2.00372003 |
109 | Lymphopenia (HP:0001888) | 2.00026118 |
110 | Skin ulcer (HP:0200042) | 1.99108990 |
111 | Cheilitis (HP:0100825) | 1.97567405 |
112 | Thrombophlebitis (HP:0004418) | 1.97559418 |
113 | Restrictive lung disease (HP:0002091) | 1.97297846 |
114 | Anorexia (HP:0002039) | 1.96790844 |
115 | Recurrent pneumonia (HP:0006532) | 1.96589059 |
116 | Basal ganglia calcification (HP:0002135) | 1.96380475 |
117 | Abnormality of the pleura (HP:0002103) | 1.95163861 |
118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.95070405 |
119 | Abnormality of B cell number (HP:0010975) | 1.94066134 |
120 | Chronic diarrhea (HP:0002028) | 1.93850235 |
121 | Skin rash (HP:0000988) | 1.91852122 |
122 | Thyroiditis (HP:0100646) | 1.91520023 |
123 | Glomerulonephritis (HP:0000099) | 1.91391097 |
124 | Abnormality of the common coagulation pathway (HP:0010990) | 1.90209364 |
125 | Polyneuropathy (HP:0001271) | 1.87979874 |
126 | Arthralgia (HP:0002829) | 1.85349286 |
127 | Splenomegaly (HP:0001744) | 1.85290779 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K14 | 4.11733968 |
2 | MAP4K1 | 4.10410272 |
3 | TYK2 | 3.87018584 |
4 | TXK | 3.30572953 |
5 | IRAK3 | 3.08200238 |
6 | JAK3 | 3.06247296 |
7 | TBK1 | 2.95262163 |
8 | IRAK4 | 2.86725272 |
9 | MAP3K13 | 2.73520844 |
10 | PRPF4B | 2.59017888 |
11 | RIPK4 | 2.57560015 |
12 | BLK | 2.46237925 |
13 | * IKBKE | 2.42609233 |
14 | JAK1 | 2.38688141 |
15 | TESK2 | 2.28712753 |
16 | ZAP70 | 2.19137198 |
17 | ERN1 | 2.17562221 |
18 | KIT | 2.14793061 |
19 | IKBKB | 2.10616905 |
20 | FGFR4 | 2.03685017 |
21 | TAOK3 | 1.89131046 |
22 | MAP3K11 | 1.73129586 |
23 | KDR | 1.50266782 |
24 | CSK | 1.50042351 |
25 | LCK | 1.48593849 |
26 | ITK | 1.46157672 |
27 | CHUK | 1.45273269 |
28 | HCK | 1.44340370 |
29 | TAOK2 | 1.43615137 |
30 | STK10 | 1.42360842 |
31 | SYK | 1.42288685 |
32 | BTK | 1.40500352 |
33 | GRK7 | 1.37079553 |
34 | SIK2 | 1.36997407 |
35 | RPS6KA4 | 1.36389401 |
36 | SCYL2 | 1.28381610 |
37 | TEC | 1.27682359 |
38 | PTK6 | 1.25469121 |
39 | TNK2 | 1.23152779 |
40 | EEF2K | 1.22792239 |
41 | JAK2 | 1.21657032 |
42 | MAP3K10 | 1.20759014 |
43 | MARK3 | 1.20095201 |
44 | CSF1R | 1.16835141 |
45 | FGFR3 | 1.15789578 |
46 | TAOK1 | 1.14257723 |
47 | TESK1 | 1.13874607 |
48 | EPHB1 | 1.13153139 |
49 | FES | 1.08432007 |
50 | SMG1 | 1.07848895 |
51 | NME2 | 1.06655873 |
52 | PIM1 | 1.05345810 |
53 | GRK6 | 1.04020156 |
54 | MAP3K1 | 1.03052474 |
55 | MATK | 1.00711865 |
56 | TTN | 0.99675645 |
57 | SIK1 | 0.98265535 |
58 | CDK12 | 0.97090061 |
59 | LYN | 0.96980073 |
60 | NLK | 0.91284220 |
61 | MAP2K3 | 0.88213556 |
62 | CDC42BPA | 0.87218681 |
63 | CAMKK2 | 0.86181121 |
64 | SIK3 | 0.82755776 |
65 | TRPM7 | 0.76760349 |
66 | BMPR2 | 0.76266293 |
67 | PIM2 | 0.72732539 |
68 | NEK9 | 0.71641882 |
69 | MAP3K8 | 0.65936368 |
70 | MST1R | 0.65141145 |
71 | PRKCQ | 0.63780100 |
72 | FLT3 | 0.62185918 |
73 | PRKD2 | 0.61754014 |
74 | PKN2 | 0.61695599 |
75 | STK4 | 0.59791824 |
76 | LRRK2 | 0.57740908 |
77 | TRIB3 | 0.57719029 |
78 | TGFBR2 | 0.57646385 |
79 | CDK6 | 0.55659844 |
80 | MAP3K7 | 0.55078653 |
81 | EGFR | 0.54508112 |
82 | DAPK2 | 0.54408952 |
83 | RPS6KA6 | 0.54038274 |
84 | FGR | 0.53679115 |
85 | MOS | 0.52010093 |
86 | PRKG2 | 0.51625376 |
87 | MAPK11 | 0.51015739 |
88 | IRAK2 | 0.48556281 |
89 | MAPK7 | 0.48035434 |
90 | CDK4 | 0.47655396 |
91 | ABL1 | 0.47557245 |
92 | RPS6KC1 | 0.45137068 |
93 | RPS6KL1 | 0.45137068 |
94 | PDPK1 | 0.45009316 |
95 | MARK2 | 0.43885993 |
96 | ARAF | 0.43830109 |
97 | EIF2AK2 | 0.43254300 |
98 | YES1 | 0.43049329 |
99 | PDGFRB | 0.42408621 |
100 | BMX | 0.42396895 |
101 | MST4 | 0.40409750 |
102 | CLK1 | 0.40107134 |
103 | PDK1 | 0.40084699 |
104 | RPS6KA2 | 0.40059115 |
105 | EPHA3 | 0.38581494 |
106 | NUAK1 | 0.37982156 |
107 | MAPK4 | 0.36538257 |
108 | PAK4 | 0.34960377 |
109 | PRKCH | 0.34613799 |
110 | HIPK2 | 0.32569027 |
111 | PRKCD | 0.32425953 |
112 | PTK2 | 0.32250810 |
113 | FYN | 0.31803595 |
114 | MAPKAPK2 | 0.31646241 |
115 | MAP2K6 | 0.30846533 |
116 | CAMK1D | 0.28725634 |
117 | BRD4 | 0.27662029 |
118 | MAP3K3 | 0.27422521 |
119 | MAP3K5 | 0.25442013 |
120 | SGK3 | 0.24489453 |
121 | RIPK1 | 0.24083762 |
122 | DAPK3 | 0.22651298 |
123 | IGF1R | 0.21748627 |
124 | MAPK3 | 0.21710988 |
125 | MAPK12 | 0.21496489 |
126 | IRAK1 | 0.21124796 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.02700093 |
2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.02626652 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.91873426 |
4 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65340404 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.49161493 |
6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.47168291 |
7 | * Measles_Homo sapiens_hsa05162 | 2.46663390 |
8 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.29547438 |
9 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.26767340 |
10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.20733121 |
11 | Allograft rejection_Homo sapiens_hsa05330 | 2.19479574 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04684964 |
13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.02070922 |
14 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.95730698 |
15 | * Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.92030454 |
16 | * Influenza A_Homo sapiens_hsa05164 | 1.91642973 |
17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.91565970 |
18 | Malaria_Homo sapiens_hsa05144 | 1.88938184 |
19 | Pertussis_Homo sapiens_hsa05133 | 1.86558894 |
20 | Asthma_Homo sapiens_hsa05310 | 1.85418707 |
21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.83156583 |
22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.83140526 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.82579333 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.79218568 |
25 | Tuberculosis_Homo sapiens_hsa05152 | 1.72718975 |
26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67433961 |
27 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.62246112 |
28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.60555454 |
29 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.57677045 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.40850644 |
31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40632176 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40519671 |
33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37197009 |
34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.36613931 |
35 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33503771 |
36 | * Hepatitis C_Homo sapiens_hsa05160 | 1.32684649 |
37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27699868 |
38 | * Hepatitis B_Homo sapiens_hsa05161 | 1.23020662 |
39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20541838 |
40 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.15762763 |
41 | Shigellosis_Homo sapiens_hsa05131 | 1.14908072 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13771438 |
43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.10661540 |
44 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10391486 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05092775 |
46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.04268776 |
47 | ABC transporters_Homo sapiens_hsa02010 | 1.02337435 |
48 | Lysosome_Homo sapiens_hsa04142 | 1.01538515 |
49 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97930085 |
50 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94539555 |
51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94301815 |
52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92528894 |
53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90934601 |
54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90475458 |
55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87285469 |
56 | Salmonella infection_Homo sapiens_hsa05132 | 0.86278279 |
57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85956525 |
58 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77066472 |
59 | Phagosome_Homo sapiens_hsa04145 | 0.76700612 |
60 | Platelet activation_Homo sapiens_hsa04611 | 0.76689685 |
61 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76068624 |
62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.72644871 |
63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.70515385 |
64 | Insulin resistance_Homo sapiens_hsa04931 | 0.68396837 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.64515747 |
66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.63412026 |
67 | Lysine degradation_Homo sapiens_hsa00310 | 0.61127481 |
68 | Endocytosis_Homo sapiens_hsa04144 | 0.58545677 |
69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57384308 |
70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57182482 |
71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55744128 |
72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55439854 |
73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.54560386 |
74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54236192 |
75 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54235200 |
76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53971772 |
77 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53321626 |
78 | Bladder cancer_Homo sapiens_hsa05219 | 0.53055211 |
79 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51454412 |
80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.50774764 |
81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46978981 |
82 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.45538141 |
83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45121079 |
84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44358483 |
85 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42912863 |
86 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42813094 |
87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41094046 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40108706 |
89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.36704291 |
90 | Prion diseases_Homo sapiens_hsa05020 | 0.36586465 |
91 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34991219 |
92 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.33584151 |
93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32842932 |
94 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32219092 |
95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32116848 |
96 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31606151 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30269800 |
98 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.30177470 |
99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29170697 |
100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28550868 |
101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27856988 |
102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.27517588 |
103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27224960 |
104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27083926 |
105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.26989358 |
106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26838491 |
107 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.26439696 |
108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.26078445 |
109 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.24154200 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22894418 |
111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.22394658 |
112 | Prostate cancer_Homo sapiens_hsa05215 | 0.21126205 |
113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20758793 |
114 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.19906617 |
115 | Colorectal cancer_Homo sapiens_hsa05210 | 0.17365602 |
116 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13959951 |
117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12772817 |
118 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.12362428 |
119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12279416 |